2280-32-2 (D-Streptamine,O-2-amino-2-deoxy-a-D-glucopyranosyl-(1&reg,Kanamycin C)

卡那霉素ç;

alpha-D-glucopyranoside, (1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2-amino-2-deoxy-;(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;KANAMYCIN C;(1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside;2280-32-2;5286U88N7P;4-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine;DTXSID3023186;CHEBI:28185;UNII-5286U88N7P;KNC;SCHEMBL418521;KANAMYCIN C [MI];C01823;(1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside;NS00011543;Q27103220;BRN 0061645;

WZDRWYJKESFZMB-FQSMHNGLSA-N

1S/C18H36N4O11/c19-4-1-5(20)16(33-18-13(28)8(21)10(25)6(2-23)31-18)14(29)15(4)32-17-9(22)12(27)11(26)7(3-24)30-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1

O([C@@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)N)[C@@H]1[C@H](C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)N)O)N)N